What Pharma Leaders Are Prioritizing This Year – Top Bets and Blind Spots

In this episode of Trending Health, we explore how the Inflation Reduction Act (IRA) is reshaping strategy across the life sciences industry.

Mindy McGrath is joined by Inizio Ignite colleagues, Scott Briggs and Ethan Johnson, to discuss how manufacturers are responding to Medicare price negotiation, Part D redesign, and increasing pressures on pricing and access.

The conversation highlights what has surprised leaders so far, how payer dynamics are evolving, and how companies are rethinking portfolio and lifecycle decisions in a more constrained market.

As future negotiation rounds approach, the episode offers a clear view into where organizations are focusing—and what they should be preparing for next.

Panel –Mindy McGrath, Scott Briggs, Ethan Johnson

Recording & Editing – Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com.